The fact that NOV and GSTM3 showed consistent associations across MR, colocalization, and SMR (with negative HEIDI) suggests that their gene expression levels may influence bladder cancer risk through a direct and singular pathway. This evidence concerns the gene GSTM3 and urinary bladder cancer.